MeMed Diagnostics
Latest round
- Series C
Last raised
- Sep 2018
Total raised
- $70M
Investors
- 10
About MeMed Diagnostics
Based in Israel, MeMed Diagnostics, Ltd.Founded in 2009 in Tirat Carmel, Israel, MeMed Diagnostics, Ltd. develops diagnostic technologies aimed at improving infectious disease management.MeMed Ltd. specializes in advanced diagnostic solutions that leverage machine learning to analyze the immune system's complex signaling. The company’s flagship product, MeMed BV®, is the first FDA-cleared host-immune response assay, designed to differentiate between bacterial and viral infections within 15 minutes. Additionally, the MeMed Key platform facilitates rapid multiplexed protein measurements, enabling healthcare providers to make informed decisions regarding acute infections. Together, these products address critical challenges in infectious diseases and inflammatory disorders, significantly reducing the risk of inappropriate antibiotic prescriptions.MeMed generates revenue through the sale of its diagnostic products, primarily focusing on B2B transactions with hospitals and healthcare facilities. The company offers its products on a transactional basis, likely involving bulk purchases or long-term agreements with healthcare providers. The specific pricing structure for their flagship products, such as MeMed BV® and MeMed Key, is not disclosed; however, it is expected that pricing strategies reflect the advanced technology and rapid diagnostic capabilities they provide.In January 2022, MeMed Diagnostics, Ltd. The firm plans to introduce new products designed to enhance diagnostic capabilities and expand its reach into additional markets, specifically targeting the United States and Europe by 2024.
Who invested in MeMed Diagnostics
10 investors across 4 rounds
See all investors in MeMed Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MeMed Diagnostics
Who invested in MeMed Diagnostics?
MeMed Diagnostics has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MeMed Diagnostics raised?
MeMed Diagnostics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did MeMed Diagnostics last raise money?
MeMed Diagnostics's most recent round on record is a Series C, in Sep 2018.
What does MeMed Diagnostics do?
Based in Israel, MeMed Diagnostics, Ltd.
Where is MeMed Diagnostics headquartered?
MeMed Diagnostics is headquartered in Tirat Carmel, Israel.
Which VCs invest in companies like MeMed Diagnostics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at MeMed Diagnostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like MeMed Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.